Literature DB >> 1613389

Subcellular localization of heparanase in human neutrophils.

Y Matzner1, I Vlodavsky, M Bar-Ner, R Ishai-Michaeli, A I Tauber.   

Abstract

The subcellular localization of a heparan sulfate degrading endoglycosidase, heparanase, was studied in human neutrophils. Unstimulated cells were disrupted by nitrogen cavitation and fractionated on a Percoll density gradient into three components, separating the plasma membranes, specific granules, and azurophilic granules. Heparanase activity was measured by gel filtration analysis of 35S-labeled degradation fragments released from subendothelial extracellular matrix (ECM) or produced during incubation with soluble, ECM-derived, heparan sulfate proteoglycans. Heparanase activity was found mainly in fractions containing the specific granules; this activity was inhibited by heparin. Freezing and thawing was not needed for recovery of the enzyme from the subcellular fraction, confirming previous data about its ready release. The mechanism of the ready release of heparanase from the specific granules requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613389     DOI: 10.1002/jlb.51.6.519

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

Review 1.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  A rapid quantitative assay for the detection of mammalian heparanase activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.

Authors:  F Mollinedo; M Nakajima; A Llorens; E Barbosa; S Callejo; C Gajate; A Fabra
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Human platelet heparanase: purification, characterization and catalytic activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 5.  Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.

Authors:  E Zcharia; S Metzger; T Chajek-Shaul; Y Friedmann; O Pappo; A Aviv; M Elkin; I Pecker; T Peretz; I Vlodavsky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

6.  Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system.

Authors:  S J Klebanoff; M G Kinsella; T N Wight
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Heparin and related drugs: beyond anticoagulant activity.

Authors:  Clive Page
Journal:  ISRN Pharmacol       Date:  2013-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.